| ULTRAGENYX PHARM. DL-,001 |
| USA |
| Gesundheit |
| US90400D1081 / A1XCY0 |
| UP0 (Frankfurt) / RARE (NASDAQ) |
| FRA:UP0, ETR:UP0, UP0:GR, NASDAQ:RARE |
| - |
| https://www.ultragenyx.co.. |
|
Ultragenyx Pharmaceutical Inc. is a biopharmaceuti..
>Volltext.. |
| 2833.96 Mio. EUR |
| 3204.85 Mio. EUR |
| 535.67 Mio. EUR |
| -432.12 Mio. EUR |
| -492.54 Mio. EUR |
| -5.04 EUR |
| 733.18 Mio. EUR |
| 180.37 Mio. EUR |
| -378.58 Mio. EUR |
| 1.28 |
| 14.46% |
| 1.58% |
| - |
| - |
| - |
| ULTRAGENYX |
| 29.12.25 |